Andere Sprachen Sernova Corp.

Aktien

SVA

CA81732W1041

SVA

Schlusskurs Toronto S.E. Andere Börsenplätze 00:00:00 01.05.2024			% 5 Tage	% 1. Jan.
0,425 ^CAD	+1,19 %		-1,16 %	-39,29 %

02.04.	Sernova Corp. gibt positives Update zum klinischen und Plattform-Portfolio	CI
19.03.	Sernova Corp. meldet Ergebnis für das erste Quartal bis zum 31. Januar 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sernova Announces AGM Voting Results	01.05.
Sernova Provides Organizational Update	25.04.
Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for its Board of Directors	22.04.
Sernova Provides Positive Clinical and Platform Portfolio Update	03.04.
Sernova Corp. Provides Positive Clinical and Platform Portfolio Update	02.04.
Sernova : INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	19.03.
Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	19.03.
Sernova : Corporate Presentation March 2024	15.03.
Sernova Corp. Announces CFO Changes	11.03.
Sernova Announces Management Developments	11.03.
Sernova Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	29.01.
Sernova Provides Recap of 2023 Accomplishments and Anticipated 2024 Milestones	29.01.
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA	27.11.
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA	27.11.
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System at the 2023 IPITA-IXA-CTRMS Joint Congress	31.10.23
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	30.10.23
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress	30.10.23
Sernova Corp. Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System? at the 2023 IPITA-IXA-CTRMS Joint Congress	30.10.23
Sernova Announces Positive Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial	27.10.23
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	27.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sernova Corp.

Aktien

SVA

CA81732W1041

SVA

Andere Sprachen

Filter